4.7 Article

Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies

期刊

JOURNAL OF NEUROLOGY
卷 267, 期 12, 页码 3444-3456

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-020-09985-z

关键词

Orthostatic hypotension; Cognitive impairment; Synucleinopathies; Parkinson's disease; Multiple system atrophy; Dementia with Lewy bodies

向作者/读者索取更多资源

Differential diagnosis between Parkinson's disease, dementia with Lewy bodies and multiple system atrophy can be difficult, especially because in early phase they might present with overlapping clinical features. Notably, orthostatic hypotension and cognitive dysfunction are common nonmotor aspects of parkinsonian syndromes and can be both present from the earliest stages of all alpha-synucleinopathies, indicating a common neurobiological basis in their strong relationship. In view of the increasing awareness about the prevalence of mild cognitive dysfunction in multiple system atrophy, the relevance of autonomic dysfunction in demented parkinsonian patients, the critical role of non-motor symptoms in clustering Parkinson's disease patients and the shift to studying patients in the prodromal phase, we will discuss some intrinsic limitations of current clinical diagnostic criteria, even when applied by movement disorder specialists. In particular, we will focus on the early coexistence of autonomic and cognitive dysfunction in the setting of overt or latent parkinsonism as pitfalls in the differential diagnosis of alpha-synucleinopathies. As early and accurate diagnosis remains of outmost importance for counselling of patients and timely enrolment into disease-modifying clinical trials, a continuous effort of research community is ongoing to further improve the clinical diagnostic accuracy of alpha-synucleinopathies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Neurosciences

Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery

Harald Hampel, Andrea Vergallo, Filippo Caraci, A. Claudio Cuello, Pablo Lemercier, Bruno Vellas, Kelly Virecoulon Giudici, Filippo Baldacci, Britta Hanisch, Marion Haberkamp, Karl Broich, Robert Nistico, Enzo Emanuele, Francisco Llavero, Jose L. Zugaza, Alejandro Lucia, Ezio Giacobini, Simone Lista

Summary: The availability of disease-modifying therapies for Alzheimer's disease will lead to a large demand for clinical and biological screening, challenging global healthcare systems. Advancements are needed in validating and qualifying minimally-invasive blood-based biomarkers to align with an evolving ATN + classification system. Novel pathophysiological mechanisms and candidate biomarkers are being integrated into blood-based liquid biopsies to drive precision medicine strategies.

NEUROPHARMACOLOGY (2021)

Article Clinical Neurology

Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region

Eleonora Del Prete, Alessio Francesconi, Giovanni Palermo, Sonia Mazzucchi, Daniela Frosini, Riccardo Morganti, Piero Coleschi, Laura Maria Raglione, Paola Vanni, Silvia Ramat, Alessio Novelli, Alessandro Napolitano, Carla Battisti, Martina Giuntini, Carlo Rossi, Chiara Menichetti, Monica Ulivelli, Valentino De Franco, Simone Rossi, Ubaldo Bonuccelli, Roberto Ceravolo

Summary: The study found a higher prevalence of COVID-19 in the PD population compared to in Tuscany and Italy. PD patients did not experience a subjective worsening of symptoms during the lockdown period, and they were also favorable to telemedicine, although there was reduced availability to perform it.

JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis

Eleonora Del Prete, Luca Tommasini, Sonia Mazzucchi, Daniela Frosini, Giovanni Palermo, Riccardo Morganti, Cristina Pagni, Gloria Tognoni, Ubaldo Bonuccelli, Roberto Ceravolo

Summary: This study aimed to investigate the language profile, especially connected speech, in early-stage PSP-RS and PD patients. The results showed that PSP-RS patients exhibited significant impairment in language domain, particularly in connected speech, compared to PD. Furthermore, the number of sentences and subordinates in the picture description task were identified as predictors of PSP diagnosis.

NEUROLOGICAL SCIENCES (2021)

Meeting Abstract Clinical Neurology

Statins in Parkinson's disease: Influence on motor progression

Giovanni Palermo

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Letter Clinical Neurology

Early Compensatory Mechanisms in LRRK2 Mutation Carriers

Giovanni Palermo, Daniela Frosini, Angelo Antonini, Roberto Ceravolo

MOVEMENT DISORDERS (2022)

Article Clinical Neurology

Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson's disease?

Eleonora Del Prete, Emmanuelle Schmitt, Sara Meoni, Valerie Fraix, Anna Castrioto, Pierre Pelissier, Roberto Ceravolo, Elena Moro

Summary: This study investigates the relationship between motor fluctuations (MFs) and neuropsychiatric fluctuations (NMFs) in Parkinson's disease (PD). The findings suggest that NMFs only temporarily match the OFF MFs in PD patients. The study emphasizes the need to further investigate the associations between non-motor and motor symptoms in PD patients to better manage NMFs.

NEUROLOGICAL SCIENCES (2022)

Review Medicine, General & Internal

Fluid Biomarkers in Alzheimer's Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments

Linda Giampietri, Elisabetta Belli, Maria Francesca Beatino, Sara Giannoni, Giovanni Palermo, Nicole Campese, Gloria Tognoni, Gabriele Siciliano, Roberto Ceravolo, Ciro De Luca, Filippo Baldacci

Summary: The diagnosis of neurodegenerative diseases is a growing social burden, and the failure of current disease-modifying therapies calls for a different approach in drug design and patient selection. The development of novel biomarkers, particularly fluid biomarkers, can improve the diagnosis, prognosis, and clinical trials of neurodegenerative diseases.

DIAGNOSTICS (2022)

Article Clinical Neurology

Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms

Sonia Mazzucchi, Eleonora Del Prete, Mauro Costagli, Daniela Frosini, Davide Paoli, Gianmichele Migaleddu, Paolo Cecchi, Graziella Donatelli, Riccardo Morganti, Gabriele Siciliano, Mirco Cosottini, Roberto Ceravolo

Summary: This study evaluated the diagnostic potential of a multimodal MRI protocol combining morphometric and quantitative susceptibility mapping (QSM) imaging in patients with determined parkinsonisms. The results showed that QSM had excellent diagnostic accuracy in distinguishing PD from PSP and good accuracy in distinguishing PD from MSA-p. Combining morphometric imaging and QSM could improve the diagnostic phase of degenerative parkinsonisms.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Review Biochemistry & Molecular Biology

COVID-19 and Parkinsonism: A Critical Appraisal

Francesco Cavallieri, Valentina Fioravanti, Francesco Bove, Eleonora Del Prete, Sara Meoni, Sara Grisanti, Marialuisa Zedde, Rosario Pascarella, Elena Moro, Franco Valzania

Summary: This review summarizes the clinical, biological, and neuroimaging features of COVID-19-related parkinsonism and discusses the possible pathophysiological mechanisms. The appearance of parkinsonism during or immediately after COVID-19 infection is a very rare event. Different mechanisms, including vascular damage and neuroinflammation, may play a role, and further long-term observational studies are needed to evaluate the association between COVID-19 infection and the development of Parkinson's Disease.

BIOMOLECULES (2022)

Article Psychology, Clinical

Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy

L. Tommasini, J. Bonaccorsi, E. Del Prete, S. Cintoli, C. Pagni, S. Mazzucchi, G. Palermo, R. Morganti, D. Frosini, G. Siciliano, G. Tognoni, R. Ceravolo

Summary: This study explored the role of neuropsychological markers in differentiating between Parkinson's Disease and Progressive Supranuclear Palsy. It found that specific qualitative scoring systems were useful in distinguishing between the two diseases, and proposed a regression model with high diagnostic accuracy.

CLINICAL NEUROPSYCHOLOGIST (2023)

Editorial Material Clinical Neurology

Clues to Reshaping Anti-α-Synuclein Immunotherapy in Early Parkinson's Disease Patients

Giovanni Palermo, Roberto Ceravolo

MOVEMENT DISORDERS (2023)

Editorial Material Clinical Neurology

Two cases of Huntington's disease unmasked by the COVID-19 pandemic

Giovanni Palermo, Alessio Di Fonzo, Alessio Francesconi, Elisa Unti, Roberto Ceravolo

NEUROLOGICAL SCIENCES (2023)

Meeting Abstract Clinical Neurology

Statins in Parkinson's Disease: Iinfluence on motor progression

G. Palermo, S. Giannoni, M. Giuntini, E. Belli, D. Frosini, G. Siciliano, R. Ceravolo

MOVEMENT DISORDERS (2021)

暂无数据